Comparison of Cypher Select and Taxus Express Coronary Stents
Launched by AARHUS UNIVERSITY HOSPITAL SKEJBY · Oct 16, 2006
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Design:
* Randomized open multicentre trial.
Patients:
* 1800 patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation.
Inclusion criteria:
* Patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation.
* Signed informed consent.
Exclusion criteria:
* Participation in other stent studies.
Randomization:
* Implantation of Taxus Express og Cypher Select stents.
Primary end-point:
* Combined end-point of cardiac death, new revascularization (PCI or CABG) or myocardial infarction ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Planned implantation of drug eluting stent
- • Written informed consent
- Exclusion Criteria:
- • Planned intervention with other stents than study stents
About Aarhus University Hospital Skejby
Aarhus University Hospital Skejby is a leading medical institution in Denmark, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pivotal part of the Aarhus University Health, the hospital specializes in a wide range of medical fields, fostering collaboration between clinicians and researchers to enhance patient outcomes. With state-of-the-art facilities and a multidisciplinary approach, Aarhus University Hospital Skejby is dedicated to conducting high-quality clinical trials that contribute to the development of new therapies and medical advancements, ensuring the highest standards of patient care and safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Anders Galloe, MD
Principal Investigator
Gentofte Hospital, Copenhagen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials